AVENTYL Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Aventyl, and when can generic versions of Aventyl launch?

Aventyl is a drug marketed by Ranbaxy and Lilly and is included in two NDAs.

The generic ingredient in AVENTYL is nortriptyline hydrochloride. There are twelve drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Aventyl

A generic version of AVENTYL was approved as nortriptyline hydrochloride by DR REDDYS LABS SA on March 30^th, 1992.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for AVENTYL?
What are the global sales for AVENTYL?
What is Average Wholesale Price for AVENTYL?

Summary for AVENTYL

US Patents:	0
Applicants:	2
NDAs:	2
Raw Ingredient (Bulk) Api Vendors:	42
Clinical Trials:	1
Patent Applications:	5,446
DailyMed Link:	AVENTYL at DailyMed

Drug patent expirations by year for AVENTYL

Recent Clinical Trials for AVENTYL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Sheppard Pratt Health System	N/A
Central Michigan University	N/A

See all AVENTYL clinical trials

US Patents and Regulatory Information for AVENTYL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ranbaxy	AVENTYL	nortriptyline hydrochloride	SOLUTION;ORAL	014685-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lilly	AVENTYL HYDROCHLORIDE	nortriptyline hydrochloride	CAPSULE;ORAL	014684-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lilly	AVENTYL HYDROCHLORIDE	nortriptyline hydrochloride	CAPSULE;ORAL	014684-002	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for AVENTYL

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ranbaxy	AVENTYL	nortriptyline hydrochloride	SOLUTION;ORAL	014685-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for AVENTYL

See the table below for patents covering AVENTYL around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Netherlands	6408512		⤷ Sign Up
Brazil	6461109		⤷ Sign Up
Switzerland	494730	Verfahren zur Herstellung von Dibenzocyclopentenen (Dibenzo cycloheptenes)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for AVENTYL

Recent Clinical Trials for AVENTYL

Make Better Decisions: Try a trial or see plans & pricing